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Spermatogonial stem cells (SSCs) maintain sper-
matogenesis throughout a man’s life and may
have application for treating some cases of male
infertility, including those caused by chemotherapy
before puberty. We performed autologous and
allogeneic SSC transplantations into the testes of
18 adult and 5 prepubertal recipient macaques
that were rendered infertile with alkylating chemo-
therapy. After autologous transplant, the donor
genotype from lentivirus-marked SSCs was evi-
dent in the ejaculated sperm of 9/12 adult and
3/5 prepubertal recipients after they reached matu-
rity. Allogeneic transplant led to donor-recipient
chimerism in sperm from 2/6 adult recipients.
Ejaculated sperm from one recipient transplanted
with allogeneic donor SSCs were injected into 85
rhesus oocytes via intracytoplasmic sperm injec-
tion. Eighty-one oocytes were fertilized, producing
embryos ranging from four-cell to blastocyst with
donor paternal origin confirmed in 7/81 embryos.
This demonstration of functional donor spermato-
genesis following SSC transplantation in primates
is an important milestone for informed clinical
translation.CellINTRODUCTIONIn 1994, Ralph Brinster and colleagues transplanted mouse
spermatogonial stem cells (SSCs) into the seminiferous tubules
of infertile recipientmice and observed donor-derived spermato-
genesis that was competent to produce viable progeny (Brinster
and Avarbock, 1994; Brinster and Zimmermann, 1994). SSC
transplantation has since become the gold standard bioassay
for experimental assessment of SSC activity (Phillips et al.,
2010) and may also have application in the human fertility clinic.
One potential clinical application of SSC transplantation is to
preserve and restore the fertility of male cancer patients
(Kubota and Brinster, 2006; Geens et al., 2008; Schlatt et al.,
2009; Wyns et al., 2010; Hermann and Orwig, 2011).
Chemotherapy and radiation treatments for cancer or other
conditions can permanently damage fertility (Mitchell et al.,
2009). Adult male patients have the option to preserve their
future fertility by cryopreserving sperm. Unfortunately, there
are no standard-of-care options to preserve the fertility of prepu-
bertal boys who are not yet producing mature sperm. For these
patients, it may be possible to isolate and freeze SSCs obtained
via testicular biopsy prior to gonadotoxic therapy and have these
cells reintroduced into their testes after cure (Brinster, 2007;
Clark et al., 2011). If results in animal models translate to the
clinic, this autologous transplantation paradigm may perma-
nently restore natural fertility. The feasibility of this approach is
supported by observations in lower animal models that SSCs
from donors of all ages, newborn to adult, can regenerateStem Cell 11, 715–726, November 2, 2012 ª2012 Elsevier Inc. 715
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Spermatogonial Stem Cell Transplantation in Primatesspermatogenesis (Shinohara et al., 2001; Ryu et al., 2003) and
that SSCs can be cryopreserved and retain spermatogenic func-
tion upon thawing and transplantation (Dobrinski et al., 1999,
2000; Brinster, 2002).
Large animal models are critical for examining the safety and
feasibility of experimental therapies before they are translated
to the clinic. SSC transplantation has been reported in seven
previous large animal studies (Table S1 available online). All of
those studies, except for one in the boar (Mikkola et al., 2006),
employed irradiation to destroy spermatogenesis and cause
infertility. There is a dearth of information on the efficacy of
SSC transplantation in chemotherapy-treated large animals,
probably due to the significant challenges associated with
clinical management of animals treated systemically with high-
dose chemotherapies that cause severe hematopoietic deficits
(Hermann et al., 2007). However, the importance of this experi-
mental paradigm should not be overlooked because high-dose
alkylating chemotherapies are used routinely for conditioning
prior to hematopoietic stem cell (HSC) transplantation and are
associated with high risk of infertility (Wallace et al., 2005; Lee
et al., 2006; Mitchell et al., 2009; Green et al., 2010).
The first large animal SSC transplants were performed in
monkeys by Schlatt and colleagues (see Table S1), who
described autologous transplants into irradiated monkey recipi-
ents in 2002 and again in 2011 (Schlatt et al., 2002; Jahnukainen
et al., 2011). Each study reported that the transplanted right
testis was larger than the untransplanted left testis in one animal,
but presence or function of donor sperm was not evaluated.
Thus, the question of whether SSC transplant can be translated
to the primate system and produce functional sperm still
remains. The translational significance of this question is high
because clinics around the world (Keros et al., 2007; Wyns
et al., 2008; Ginsberg et al., 2010; Sadri-Ardekani et al., 2011;
Oktay, 2011; Orwig et al., 2011; Schlatt and Kliesch, 2012) are
already cryopreserving testicular tissue for boys in anticipation
that SSCs in that tissue can be used to restore fertility via
autologous SSC transplantation, autologous tissue grafting,
xenografting, or in vitro germ cell differentiation (Brinster, 2007;
Rodriguez-Sosa and Dobrinski, 2009; Sato et al., 2011; Clark
et al., 2011). Establishing the feasibility of SSC transplantation
in the primate model will have important implications for how
testicular tissue should be processed and for educating patients
and physicians about the potential downstream applications.
We previously described a nonhuman primate model of
cancer survivorship in rhesus macaques where infertility was
caused by alkylating chemotherapy (busulfan) (Hermann et al.,
2007). We employed that model in the current study to examine
the feasibility of SSC transplantation in prepubertal and adult
rhesus macaques, which have testis biology, endocrine regula-
tion, and immune function that is similar to that of humans (Plant
and Marshall, 2001; Hermann et al., 2010; Messaoudi et al.,
2011). Prophylactic autologous peripheral blood stem cell
(PBSC) transplant (Donahue et al., 2005; Kang et al., 2006) was
used to counteract the hematopoietic deficits in all animals.
This complex experimental design involving HSC and SSC trans-
plantation models the clinical scenario of HSC (bone marrow or
PBSC) transplant patients who are at high risk for infertility (Wyns
et al., 2010). Our results indicate that transplanted SSCs can
regenerate spermatogenesis in busulfan-treated primates and716 Cell Stem Cell 11, 715–726, November 2, 2012 ª2012 Elsevier Inproduce functional sperm capable of fertilizing oocytes and
leading to preimplantation embryo development.
RESULTS
SSC Transplantation by Ultrasound-Guided Rete Testis
Injection in Monkeys
Schlatt and coworkers pioneered ultrasound-guided rete testis
injection into monkey testes in 1999 (Schlatt et al., 1999) and
this technique has now been applied to introduce testis cell
suspensions into the seminiferous tubules of several large animal
species (Schlatt et al., 1999, 2002; Honaramooz et al., 2003;
Izadyar et al., 2003; Mikkola et al., 2006; Kim et al., 2008; Herrid
et al., 2009). In contrast to a typical rodent SSC transplant where
the testis efferent ducts and/or rete testes are accessed surgi-
cally through an abdominal incision (Ogawa, 2001), ultrasound-
guided rete testis injection does not require surgery. Briefly,
ultrasound is used to visualize the rete testis and guide the
injection needle through the scrotal skin and into the rete testis
space, which is contiguouswith all seminiferous tubules (Figure 1
and Movie S1). With this approach, we introduced an average
of 1,041 ± 82 ml of cell suspension into the rete testis and
seminiferous tubules of adult recipients and 222 ± 26 ml into
juvenile recipients. Cell concentrations ranged from 58 to
232 3 106 viable cells/ml; an average of 88 3 106 viable cells
were injected per adult testis and 45.8 3 106 viable cells were
injected per juvenile testis (Table S2).
Transplanted Autologous SSCs Produce
Spermatogenesis in Busulfan-Treated Macaques
To assess the regenerative capacity of primate SSCs, we
performed a series of autologous transplant experiments in
busulfan-treated macaques (Hermann et al., 2007). Because
the doses of busulfan required to deplete endogenous sper-
matogenesis are also myelosuppressive, all animals received
autologous PBSC transplants to support rapid hematopoietic
recovery (Figure 2). Testis cells were obtained via hemicastration
or biopsy of one testis and were cryopreserved prior to busulfan
chemotherapy.
In order to distinguish transplanted SSCs and their progeny
from endogenous cells, we treated donor cells with lentiviral
vectors containing Ubiquitin-C (UBC)-eGFP, elongation factor
1a (EF1a)-GFP, or EF1a-mCherry transgene inserts (Table S2)
prior to transplant. This approach permanently marks donor cells
and allows detection of the labeled donor cells in tissue or ejacu-
lated sperm by their genotype (e.g., a specific lentiviral DNA
sequence).
Approximately 10–12 weeks after busulfan treatment (corre-
sponding to the time when sperm counts reach 0 in adults), cells
were thawed, treated with lentivirus, and transplanted back into
the other testis of the same animal (Figure 2). Lentivirus-treated
autologous SSCs were transplanted into the seminiferous
tubules of 12 adult and 5 prepubertal recipient macaques by
ultrasound-guided rete testis injection. Polymerase chain reac-
tion (PCR) was used to detect sperm produced from lentivirus-
marked SSCs in the ejaculates of recipient animals. Overall,
spermatogenesis was evident in 11/12 adult and 5/5 prepubertal
(after puberty) recipients after transplant (Figure 3A and Tables
S2, S3, and S4).c.
Figure 1. Rhesus SSC Transplantation by Ultrasound-Guided Rete
Testis Injection
Donor testis cells (including SSCs) are introduced into recipient seminiferous
tubules via injection into the rete testis space. (A) The rete testis in rhesus can
be visualized by ultrasound as a linear echo-dense structure and (B) ultrasound
is used to guide an echo-dense injection needle into the rete testis space,
allowing cells to be injected by slow, positive pressure. (C) After this injection,
presence of dye in the ductules of the caput epididymis (inset), which is
contiguous via the efferent ducts with the rete testis, confirmed successful
injection. (D) Bisection of the transplanted testis revealed that blue dye radi-
ated from the rete testis into approximately 60%–80%of seminiferous tubules.
(E and F) Subsequent evaluation of intact seminiferous tubules confirmed
the presence of blue dye in the lumen of seminiferous tubules. Scale bar = 1 cm
(C and D), 500 mm (E), and 100 mm (F). See also Movie S1.
Figure 2. Experimental Timeline for Recipient Preparation and SSC
Transplantations
This cartoon shows relative timing of experimental procedures for recipient
animals, including autologous transplants of peripheral blood stem cells
(PBSCs) used to restore the hematopoietic system after busulfan chemo-
therapy. Indwelling central venous catheters were placed in the right internal
jugular vein at the time of testicular tissue harvesting or approximately 5 weeks
before PBSC harvest via apheresis. Autologous blood was collected for
5 weeks (red triangles) and pooled to prime the apheresis tubing set. Animals
received daily subcutaneous injections with the cytokine G-CSF (and in some
cases, SCF) (green triangles) for 6 days to mobilize hematopoietic stem cells
from the bone marrow into the general circulation. PBSCs were collected on
day 0 by apheresis using the indwelling central line for venous access. Twenty-
four hours after completing apheresis, animals were treated with busulfan
(labeled arrow). Approximately 42 hours after completing apheresis (18 hr
after busulfan treatment), animals were transfused with autologous PBSCs
collected by apheresis. Two days later, animals received one subcutaneous
injection of neulasta (long-acting G-CSF) to stimulate rapid expansion of
engrafted stem cells and hematopoietic recovery. Animals were monitored
closely for hematopoietic deficits with weekly (or more frequent) complete
blood count (CBC, orange triangles). Approximately 10–12 weeks after
busulfan treatment, animals received SSC transplants (when sperm counts
were 0 for 2 consecutive weeks). Weekly ejaculated sperm counts (blue
triangles) measured the effect of busulfan on spermatogenesis and the
progression of spermatogenic recovery after transplant. See also Figure S1
and Table S2.
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roughly 42–44 days, followed by 10.5 days of epididymal trans-
port time (Amann et al., 1976; Clermont and Antar, 1973;
Hermann et al., 2010). Recovery of spermatogenesis to normal
levels (R15 3 106) was observed in adult autologous recipients
an average of 40.1 ± 4.9 weeks after busulfan treatment (11 of 12
adults; ranged from 15 to 63 weeks; Table S3). In our previous
study, recovery of spermatogenesis from endogenous SSCs
occurred by 24 weeks after a low dose of busulfan (4 mg/kg)
that did not eliminate endogenous SSCs; spermatogenic
recovery was not observed in animals treated with the higher
busulfan doses (8 and 12 mg/kg) employed in this study
(Hermann et al., 2007). The time to spermatogenic recovery in
this study can likely be attributed to the substantial depletion
of the endogenous SSC pool, which is not completely replen-
ished by transplanted SSCs. Thus, spermatogenesis originates
from sporadic foci of individual endogenous and/or transplanted
SSCs that must expand laterally to repopulate the seminiferous
tubules as well as differentiate to produce sperm. These factorsCellapparently prolong the time required to reach a steady state
threshold sufficient to produce normal sperm counts in the
ejaculate.
PCR genotyping for the lentiviral backbone indicated stable
donor signal in the ejaculates of 9/12 adult and 3/5 prepubertal
autologous recipients (Figure 3B and Tables S2, S3, and S4).
Donor signal was considered stable when lentiviral genotype
was observed in at least four separate semen samples
collected over the course of at least three months. Results
from autologous recipient M037 are shown in Figure 3 where
sperm reappeared in the ejaculate between 20 and 30 weeks
after transplant (Figure 3A). Donor lentiviral sequence was
detected by PCR coincident with the appearance of sperm
(Figure 3B). Overall, PCR signal from lentivirus marked SSCs
decayed over time (see Tables S3 and S4), suggesting a low effi-
ciency of virus-marked SSC engraftment. Histological compar-
ison of the testis and cauda epididymis from M037 (Figure 3C)
clearly demonstrates more spermatogenic recovery (60% of
seminiferous tubule cross-sections contained spermatogenesis)
compared with a transplant recipient that failed to exhibit
sperm in the ejaculates after transplant (M214; Figure 3D) and
had spermatogenesis in only 24% of tubule cross-sections.
For reference, all seminiferous tubules were devoid of germ cellsStem Cell 11, 715–726, November 2, 2012 ª2012 Elsevier Inc. 717
Figure 3. Spermatogenic Recovery follow-
ing Autologous SSC Transplantation
(A) Weekly sperm counts (total sperm per ejacu-
late) are shown for one autologous recipient (M037
treated with 10 mg/kg busulfan). In this animal,
busulfan was administered at week 14 (noted by
blue arrow) relative to SSC transplant at week 0.
(B) DNA from each ejaculate containing sperm
was genotyped by PCR for a 1.1 kb segment of the
lentiviral backbone. Negative controls included
prebusulfan/pretransplant (pre-TP) ejaculates,
ejaculates from untransplanted controls (nega-
tive), and H2O. Positive controls included cultured
testis cells treated with lentivirus (M306+ and
M307+) and dilutions of lentiviral plasmid DNA
(100 pg, 10 pg, 1 pg, and 0.1 pg). Histological
(hematoxylin and eosin staining) comparison of
testicular parenchyma before and after busulfan
treatment (at necropsy) as well as the cauda
epididymis after busulfan treatment reveals the
degree of spermatogenesis in (C) M037, which
exhibited successful transplant engraftment
based on presence of sperm in the ejaculate (60%
of tubule cross-sections contained spermatogen-
esis; necropsied 80 weeks after busulfan), and (D)
transplant recipient M214, which never exhibited
sperm in the ejaculate after transplant (24% of
tubule cross-sections contained spermatogen-
esis; necropsied 67 weeks after busulfan). (E)
Histology from the testis and epididymis of an
untransplanted animal, M104 (no spermatogen-
esis evident; necropsied 26 weeks after busulfan),
illustrates the appearance of an azoospermic
(empty) testis after busulfan treatment. Scale
bars = 50 mm. See also Tables S2, S3, and S4.
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after busulfan treatment (M104; Figure 3E). We were unable to
observe fluorescent segments of seminiferous tubules (i.e.,
those marked by the lentivirus and those that regenerated sper-
matogenesis) after systematic evaluation of each autologous
recipient testis at necropsy by epifluorescence microscopy.
The failure to observe lentiviral reporter expression may result
from epigenetic silencing of the transgene, insufficient expres-
sion for this detection mode, or both.
The best way to demonstrate that transplanted SSCs produce
functional sperm is to demonstrate their ability to fertilize
oocytes. Unfortunately, our autologous transplant approach
was not amenable to fertilization studies because the efficiency
of marking SSCs was very low (data not shown). In addition, we718 Cell Stem Cell 11, 715–726, November 2, 2012 ª2012 Elsevier Inc.were not able to distinguish fluorescence
from lentivirus-marked sperm from auto-
fluorescence that was observed in most
ejaculates (data not shown). Fertilizing
oocytes from a random population of
sperm of which only a very small percent-
age were genetically marked was not
practical. Therefore, we performed addi-
tional experiments using an allogeneic
recipient approach in which all donor
sperm had unique DNA microsatelliteallele profiles that could be distinguished from those of endoge-
nous recipient sperm.
Transplanted Allogeneic SSCs Regenerate
Spermatogenesis and Produce Functional Sperm
Weutilized an allogeneic transplant paradigmwhere donor testis
cells from unrelated individual animals were transplanted into
recipient testes. While some previous reports demonstrated
that transplanted allogeneic testis cells were tolerated in large
animal models allowing engraftment of unrelated donor SSCs
(Honaramooz et al., 2002, 2003; Kim et al., 2008), SSCs from
unrelated donors failed to regenerate spermatogenesis in bull
testes (Izadyar et al., 2003) (Table S1). Thus, the potential for
immune effects on SSC engraftment is unclear. Therefore, donor
Cell Stem Cell
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reactivity to donor antigens using multiple lymphocyte reaction
(MLR; data not shown) analysis (Ezzelarab et al., 2008). In addi-
tion, five of six allogeneic recipients were treated with an immune
suppression regimen (anti-CD154; Table S2) (Kirk et al., 1999).
We discriminated sperm originating from donor and recipient
SSCs using microsatellite fingerprinting, as described previ-
ously, to detect donor sperm production in SSC-transplanted
dogs (Kim et al., 2008).
All six allogeneic recipients exhibited low levels of spermato-
genic recovery in the posttransplant period of evaluation (Fig-
ure 4A and Tables S2 and S3). Microsatellite DNA fingerprinting
revealed donor/recipient chimerism in sperm from two of the six
allogeneic recipients (M212 and M027, Tables S2 and S3).
Sperm retrieved from the left cauda epididymis at necropsy
from animal M212 exhibited a minor peak of donor signal (donor
M214; 236 bp and 244 bp alleles at locus DS11S2002; 194 bp
and 244 bp alleles at locus D12S67) amidst a background of
recovering endogenous spermatogenesis (Figures 4B–4D).
Donor signal was not detectable in ejaculated sperm from
M212 likely due to inflammation in the left epididymis evident
in the posttransplant period and confirmed at necropsy, prevent-
ing donor sperm transit to the ejaculate (data not shown). A
second allogeneic recipient, M027, produced ejaculated sperm
exhibiting donor signal (donor M092; 187 bp allele at locus
D3S1768; 263 bp allele at locus D17S1300) for more than
17 months (50 total samples) (Figure 4E–4G). Thus, these data
show that transplanted allogeneic SSCs produce sperm in
recipient testes. To quantify the degree of donor sperm produc-
tion as a function of time, we identified single nucleotide poly-
morphisms (SNPs) that distinguish donor sperm from recipient
sperm essentially as described previously (Alizadeh et al.,
2002; Kim et al., 2008). We screened 23 SNPs reported in the
Monkey SNP database at Oregon National Primate Research
Center (Khouangsathiene et al., 2008), but none distinguished
donor and recipient and/or were suitable for qPCR. How-
ever, while screening one reported SNP (rs4543622) within the
class II major histocompatibility complex transactivator (CIITA)
locus, we identified a previously unreported SNP for which the
recipient (M027) was homozygous for one allele (G) and the
donor (M092) heterozygous both alleles (A/G). Standard
curves for the relative abundance of each allele as previously
described were used to determine the percent of donor
chimerism in DNA isolated from recipient M027 following
monthly semen samples collected between 3 and 17 months
after transplant (Figure 4H). We observed a consistent level of
donor (M092) chimerism (ranging from 1.7 to 17.2%) in M027
sperm samples for the duration of the 14 months analyzed
(Figure 4H).
To assess function of donor (M092) sperm, ejaculated sperm
from recipient M027 (collected 30 weeks after transplant) were
used to fertilize rhesus oocytes by intracytoplasmic sperm injec-
tion (ICSI) (Hewitson et al., 1999; Mitalipov et al., 2006). Of 85
oocytes injected, 81 (95%) were fertilized (formed male and
female pronuclei) and subsequently cleaved (Figure 5 and Table
S5). Upon in vitro culture, 23% of embryos reached the blasto-
cyst stage with normal morphology (Table S5). To determine
sire by microsatellite DNA fingerprinting, all blastocysts and
arrested embryos were individually harvested and used forCellwhole-genome DNA amplification. Genotyping was done for
the gender marker AME to determine sex of embryo and for eight
microsatellite loci, two of which (DXS2506 and D15S823) defin-
itively discriminate the genotype of the SSC donor (M092) from
the transplant recipient (M027) and oocyte donors (Figure 5
and Table S6). In this genotyping paradigm, the 286 bp allele
at the X-linked locus DXS2506 and the 337 bp allele at locus
D15S823 were both unique to M092 and their presence in an
embryo could only arise from M092 paternal contribution (Fig-
ure 5 and Table S6). Of the 81 embryos genotyped, 7 exhibited
definitive donor (M092) sire, 3 of which advanced to the morula
stage of preimplantation development (Figure 5 and Table S6).
Since DXS2506 is an X-linked marker, male (XY) embryos,
including three XY M092-sired embryos (embryos 1, 8 and 63;
Figures 5L and 5O and Table S6), displayed only the maternal
allele at this locus. M092 donor paternal contribution in these
embryos was confirmed by the presence of the 337 bp allele at
locus D15S823. These results indicate that sperm generated
from transplanted primate SSCs are competent for fertilization
and preimplantation embryo development.
DISCUSSION
Adult stem cell transplantation for homologous tissue regenera-
tion was first described for primates in the 1950s when bone
marrow stem cells were used to reconstitute the hematopoietic
systems of monkeys and humans treated with chemotherapy
or radiation (Crouch and Overman, 1957; Thomas et al.,
1957). Large animals, primarily the dog andmonkey, were instru-
mental for establishing the safety, feasibility, and range of
applications for bone marrow transplantation. Today, approxi-
mately 50,000 bone marrow or HSC transplant procedures are
performed worldwide each year for diseases ranging from
cancer to thalassemia, sickle cell anemia, and autoimmune
and immune-deficiency disorders (Appelbaum, 2007; Powell
et al., 2009).
Like hematopoiesis, spermatogenesis is a highly productive
stem-cell-based system that produces millions of sperm per
gram of tissue each day (Sharpe, 1994). This productivity is
possible because a relatively small stem cell pool generates
progeny that undergo several rounds of transit-amplifying
divisions before producing the terminally differentiated sperm
(Potten, 1992). Two sequelae of highly productive stem-cell-
based systems are (1) that they can become targets of chemo-
therapy or radiation treatments that damage rapidly dividing
cells (Potten, 1995; Meistrich, 1993; Mauch et al., 1995) and (2)
that transplantation of a small number of stem cells is adequate
to functionally reconstitute the dependent systems (e.g., hema-
topoiesis and spermatogenesis) (Potten et al., 1979; Potten,
1992; Osawa et al., 1996; Ogawa et al., 2000; Shinohara et al.,
2001; Copelan, 2006). Here we demonstrate the feasibility of
SSC transplantation in a nonhuman primatemodel that is infertile
due to alkylating chemotherapy (busulfan) and suggest that this
technique has application for restoring the fertility of cancer
survivors or bone marrow transplant recipients.
SSC transplantation has now been reported in mice, rats,
monkeys, goats, bulls, pigs, sheep, and dogs (Brinster and
Avarbock, 1994; Brinster and Zimmermann, 1994; Ogawa
et al., 1999; Schlatt et al., 2002; Honaramooz et al., 2003; IzadyarStem Cell 11, 715–726, November 2, 2012 ª2012 Elsevier Inc. 719
Figure 4. Donor Spermatogenesis in Two Allogeneic Transplant Recipients Determined by Microsatellite DNA Fingerprinting of Recipient
Sperm
(A) Weekly sperm counts (total sperm per ejaculate) from two allogeneic recipients treated with 8mg/kg busulfan (M212; treated with busulfan on week11, dark
blue arrow) or 11 mg/kg busulfan (M027; treated with busulfan on week 9, light blue arrow); sperm from M027 (inset) are shown as examples. DNA from each
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Spermatogonial Stem Cell Transplantation in Primateset al., 2003; Mikkola et al., 2006; Kim et al., 2008; Herrid et al.,
2009). Among the seven other large animal SSC transplant
studies reviewed in Table S1, four reported evidence of donor
sperm in the ejaculate (goat, boar, dog, and sheep) and two
reported functional sperm (goat and sheep) that produced
donor-derived progeny. Although the first large animal SSC
transplants were performed in monkeys in 2002 (Schlatt et al.,
2002), evidence of donor sperm from transplanted SSCs was
lacking until the present study. It is important to demonstrate
that transplanted SSCs can produce sperm in higher primate
models that have the greatest relevance to human testis
anatomy and physiology. It is equally important to demonstrate
in primates that the testicular environment is competent to
support spermatogenesis from transplanted SSCs following
chemotherapy or radiation. Schlatt and colleagues previously
reported SSC transplant in nonhuman primates that were
rendered infertile by testicular irradiation (Schlatt et al., 2002;
Jahnukainen et al., 2011). To date, SSC transplantation into a
chemotherapy-treated large animal recipient has been reported
only in the pig (Mikkola et al., 2006). Our results indicated that
SSCs from prepubertal or adult rhesus macaques could engraft
chemotherapy-treated recipient testes and generate spermato-
genesis, including the production of donor sperm that were
competent to fertilize rhesus oocytes resulting in preimplantation
embryo development.
We found evidence of donor spermatogenesis from both
autologous and allogeneic transplant recipients and donor
sperm function was evaluated in one allogeneic recipient
(M027, the recipient of transplanted SSCs from M092). Donor
spermatogenesis in autologous recipients was generally tran-
sient in recipient semen samples, appearing several times during
posttransplant follow-up and sometimes in a cyclic manner. This
result could be linked to a low efficiency of engraftment from
virus-marked donor SSCs. Allogeneic recipient M027, on the
other hand, demonstrated steady donor spermatogenesis that
did not decline over time. The function of donor (M092) sperm
in the ejaculates of recipient M027 (which contained a mixture
of M092 and M027 sperm) was assessed by ICSI of rhesus
oocytes and was conducted in the Assisted Reproductive
Technology/Embyronic Stem Cell Support Core of the Oregon
National Primate Research Center (by K.M, C.R., and S.M).
In vitro fertilization (IVF) is an alternative approach to test sperm
function that would also assess the ability of donor sperm to
penetrate the zona pellucida. The efficiency of IVF is similar to
ICSI when using sperm from proven male donors. However,
since the males used in this study were not proven breeders,
ICSI was selected as the approach most likely to produceejaculate containing spermwas genotyped bymicrosatellite DNA fingerprinting to
showed evidence of donor spermatogenesis.
(B–D) Epididymal sperm obtained at necropsy from recipient M212 contained a
examined.
(E–G) Ejaculated sperm from M027 (collected 14 weeks after transplant) also d
microsatellite loci examined. This result persisted for at least 17months after trans
electropherograms and alleles for each animal or sample are indicated at the bot
noted by bold/colored text.
(H) Allelic discrimination qPCR (TaqMan probes) was used for SNP genotyping to
between 3 and 17months after transplant. Shown is the degree of M092 genotype
locus. Percent donor genotype was determined by standard curve with known a
Additional information about the specific samples used for SNP analysis is indic
Cella definitive outcome with donor-derived embryos. The ICSI
approach also eliminated the potential for contamination of
genotyping results with a mixture of donor and endogenous
recipient sperm. The ability of M092 SSC-derived donor sperm
to fertilize rhesus oocytes by ICSI and stimulate early embryo
development suggests that they were functionally normal.
In future studies it will be important to demonstrate that donor-
derived embryos can be transferred to surrogate females for the
production of viable donor-derived offspring. This was consid-
ered premature in the current study because only 7/81 embryos
(8.6%, Tables S5 and S6) had the donor genotype. Embryo
biopsy to select only donor type embryos for transfer was not
considered feasible and pregnancy rates after transfer are about
25% (Bavister et al., 1984; Wolf et al., 1989, 2004; Chan et al.,
2001). Therefore, the chances of achieving donor type progeny
would be about 2.15% (8.6% donor embryos3 25% pregnancy
rate). Besides the prohibitive cost, there were an insufficient
number of recipient females available to reasonably expect
donor offspring in this study. These challenges were less
onerous in herd animal species where a single SSC transplant
recipient could be used to fertilize a herd of females by natural
breeding (Honaramooz et al., 2003) or artificial insemination
(Herrid et al., 2009). Improvements in recipient preparation to
more completely eliminate endogenous spermatogenesis,
combined with development of donor SSC enrichment strate-
gies (Hermann et al., 2009, 2011), should substantially increase
the proportion of donor sperm and enhance the opportunity to
produce donor offspring in future nonhuman primate studies.
Due to concerns about immune rejection of cells from unre-
lated animals, five out of six allogeneic transplant recipients in
this study were treated with antibodies against CD154 (Kirk
et al., 1999), which blocks the T cell costimulatory pathway.
Donor spermatogenesis was observed in 2/5 immune-sup-
pressed recipients, but not in the one nonsuppressed recipient
(Table S2). Beginning in meiosis, spermatocytes and their
progeny express novel autoantigens that are tolerated by the
immune system, allowing production of genetically divergent
gametes. Multiple mechanisms regulate immune privilege in
the testis including the blood-testis barrier that limits access of
immune components to the differentiated germ cells via Sertoli
cell tight junctions, and somatic cell production of soluble factors
(e.g., FAS ligand) that suppress the rejection of immunologically
disparate cells (Fijak and Meinhardt, 2006). Testicular immune
privilege has been used to explain the success of allogeneic
SSC transplants between unrelated, immune-competent indi-
viduals that were previously reported in several large-animal
species (Honaramooz et al., 2002, 2003; Mikkola et al., 2006;determine the presence of donor genotype. Both of these allogeneic recipients
mixture of M212 recipient and M214 donor signal at the two microsatellite loci
emonstrated a mixture of M027 recipient and M092 donor signal at the two
plant with analysis ongoing. Microsatellite loci are noted above each column of
tom right of each electropherogram panel. Discriminating alleles for donor are
determine the degree of M092 donor spermatogenesis in M027 sperm samples
(%) in each spermDNA sample based on presence of SNPs in the rhesusCIITA
mounts of donor and recipient gDNA.
ated in Table S3. See also Table S2.
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Figure 5. Donor-Derived Sperm in Allogeneic Recipient Rhesus Macaques Are Functional
Ejaculated sperm from allogeneic recipient M027 (collected 30 weeks after transplant) were used to fertilize rhesus oocytes by intracytoplasmic sperm
injection (ICSI).
(A) Pronuclear stage zygote produced using sperm from M027 (see Figure 4).
(B–G) Subsequent in vitro culture resulted in embryos ranging from two-cell to blastocysts.
(H–O) Following whole-genome amplification, microsatellite DNA fingerprinting at two tetranucleotide repeat loci (DXS2506 and D15S823) confirmed SSC
transplant donor (M092) paternity in 7 of 81 embryos generated from M027 sperm. Microsatellite profiles of four M092 donor-derived embryos are shown in
panels (L)–(O). Embryo 1 (L) was from dam 28510 and embryos 49, 51, and 63 (M–O) were from dam 25168. Microsatellite loci are noted above each column of
Cell Stem Cell
Spermatogonial Stem Cell Transplantation in Primates
722 Cell Stem Cell 11, 715–726, November 2, 2012 ª2012 Elsevier Inc.
Cell Stem Cell
Spermatogonial Stem Cell Transplantation in PrimatesKim et al., 2008). Although animal numbers in this study were not
sufficient to demonstrate that immune suppression was re-
quired, our data clearly indicated that cells from unrelated donor
animals were tolerated in immune-suppressed nonhuman
primates.
Several promising techniques are in the research pipeline (i.e.,
SSC transplantation, testicular tissue grafting or xenografting,
and in vitro development of gametes) that may allow patients
receiving gonadotoxic therapies to preserve their future fertility
(Brinster, 2007; Rodriguez-Sosa and Dobrinski, 2009; Sato
et al., 2011). SSC transplantation has the unique potential to
regenerate spermatogenesis in the autologous environment of
the seminiferous tubules, enabling the recipient male to father
his own genetic children, possibly through normal coitus. As
with hematopoiesis, large animal models that are relevant to
human anatomy and physiology will be important for translating
the SSC transplantation technique to the human fertility clinic.
Considering the successful regeneration of spermatogenesis in
the nonhuman primate model reported here and the fact that
patients are already preserving testicular tissue and/or cells,
clinical translation of the SSC transplantation technique appears
imminent. Responsible development of the technology in a
clinically relevant nonhuman primate system will help to address
issues of safety and feasibility. As with hematopoiesis, the
clinical significance and breadth of applications for SSC trans-
plantation will ultimately be established in human patients.
EXPERIMENTAL PROCEDURES
Animals
All experiments utilizing animals were approved by the responsible Institutional
Animal Care and Use Committees of Magee-Womens Research Institute and
the University of Pittsburgh (Assurance #A3654-01) and the Oregon National
Primate Research Center, Oregon Health and Sciences University (Assurance
#A3304-01) and were performed in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
Preparation of Donor Rhesus Macaque Testis Cell Suspensions
Testis tissue was collected from rhesus macaques by hemicastration or
subcapsular biopsy. For biopsies, less than 30% of the testicular parenchyma
was removed (3.8g–8.7g) through a transverse incision in the tunica albuginea
on the lateral side of the right testis. In one case (M036), the biopsied testis was
later removed by hemicastration due to formation of an abscess. Cells were
recovered from testicular parenchyma using a two-step enzymatic digestion
procedure, cryopreserved, and stored in liquid nitrogen, as described
(Hermann et al., 2007, 2009).
Busulfan Treatment
Recipient animals were treated with the alkylating chemotherapeutic agent
busulfan (Busulfex IV; PDL BioPharma, Fremont, CA), at doses of 8, 10, 11,
or 12mg/kg (Table S2). Busulfex was diluted in physiological saline and admin-
istered intravenously at 0.6 mg/ml over 10–20 min.
PBSC Transplants
Autologous transplants of PBSCswere employed to restore the hematopoietic
system after busulfan treatment. Briefly, PBSCs were mobilized with six, daily
subcutaneous injections with the cytokines G-CSF (10 mg/kg/day, Neupogen;
Amgen; Thousand Oaks, CA) and SCF (200 mg/kg/day; Amgen) or G-CSFelectropherograms and alleles for each animal or sample are indicated in the up
noted by bold/colored text. In cases where embryos were male (i.e., XY; panels L
simply noted by Y. In both cases M092 paternal origin could be confirmed by th
See also Tables S5 and S6.
Cellalone (20 mg/kg/day), essentially as described (Figure 2) (Donahue et al.,
2005). PBSC collections were performed by apheresis using either a Spectra
or Spectra Optia apheresis device (Caridian BCT; Lakewood, CO). Twenty-
four hours after apheresis, animals were treated with busulfan, and 18 hr
later animals received autologous PBSC transfusions (Figure 2). Two days
later, animals received one subcutaneous injection of long-acting G-CSF
(300 mg/kg; Neulasta, Amgen). Additional details are available in the Supple-
mental Experimental Procedures.
Histology
Portions of testicular parenchyma and epididymis collected above and
at necropsy were fixed with Bouin’s solution (Accustain; Sigma-Aldrich,
St. Louis, MO), paraffin embedded, sectioned (5 mm), and stained with hema-
toxylin and eosin.
SSC Transplant
Spermatogonial stem cell transplants were performed 9–15 weeks after
busulfan treatment (autologous: unilateral; allogeneic: bilateral). In biopsied
animals, autologous transplants were performed into the contralateral testis.
Cryopreserved donor cells were recovered for transplant from storage in liquid
nitrogen, as described (Hermann et al., 2007, 2009). In some cases, donor cells
were enriched for spermatogonia, including SSCs, on a 24% Percoll cushion
(GE Healthcare Life Sciences, Piscataway, NJ) prior to transplant (see Fig-
ure S1 and Table S2). Cells were then suspended at approximately 100 3
106 cells/ml in MEMalpha medium (Invitrogen) containing 10% FBS, 20%
trypan blue, 20% Optison (ultrasound contrast agent; GE Healthcare, Wauke-
sha, WI) and 0.7 mg/ml DNase I in a total volume of %1ml, depending on
recipient testis size and available cells. SSC transplants were performed using
ultrasound-guided rete testis injections (Figure 1 and Movie S1). For this
purpose, a 13 MHz linear superficial probe was used to visualize the rete testis
space on a MicroMaxx ultrasound machine (Sonosite, Bothell, WA) and guide
a 25G 2’’ spinal needle into the rete testis. Cells were injected under slow
constant pressure and chased with saline.
Lentiviral Treatment of Donor Testis Cells
For autologous transplants, donor cells were treated with lentiviral vectors
modified from the FUGWconstruct originally described by Lois and coworkers
(Lois et al., 2002). Details of virus constructs and viral treatments are available
in the Supplemental Experimental Procedures.
Immune Suppression
Five of six allogeneic transplant recipients were treated with human/mouse
chimeric anti-CD154 IgG 5C8 (NIH Nonhuman Primate Reagent Resource,
Beth Israel Deaconess Medical Center, Boston, MA) at 20 mg/kg on d1,
d0, d3, d10, d18, d28, and monthly thereafter to block the T cell costimulatory
pathway and prevent T cell-mediated rejection of the grafted cells (Kirk et al.,
1999).
Semen Collection and Analysis
Semen samples were collected from experimental animals at weekly intervals
before and after busulfan treatment, as described (Gould and Mann, 1988).
Total sperm count per ejaculate was determined by hemocytometer. Genomic
DNA was extracted from sperm samples and assessed for donor genotype by
PCR for lentivirus sequence or by microsatellite DNA fingerprinting (see
Supplemental Experimental Procedures).
Microsatellite DNA Fingerprinting
Genomic DNA isolated from sperm of allogeneic transplants or amplified from
embryos was used for microsatellite repeat fingerprinting (details in the
Supplemental Experimental Procedures). Primer sequences and primer
concentrations in multiplexed PCR are described elsewhere (Larsen et al.,
2010).per right of each electropherogram panel. Discriminating alleles for donor are
and O), paternal contribution at the X-linked DXS2506 locus was nil, and thus,
e D15S823 locus.
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TaqMan probe-based allelic discrimination qPCR was used essentially as
described (Alizadeh et al., 2002; Kim et al., 2008) to detect an SNP in the rhe-
sus CIITA locus that distinguishes genomic DNA from the donor (M092) and
recipient (M027) of an allogeneic SSC transplant. See the Supplemental
Experimental Procedures for additional details.
ICSI, Embryo Culture, and Whole-Genome Amplification
Controlled ovarian stimulation was performed on two female rhesusmacaques
as previously described (Byrne et al., 2007). Oocytes were collected and
fertilized with M027 sperm by ICSI, and resulting embryos were cultured as
described (Hewitson et al., 1999; Mitalipov et al., 2006). Following ICSI and
in vitro development, individual embryos were placed into 8 ml nuclease-free
water. Genomic DNA from each embryo was amplified using the WGA4
GenomePlex Single Cell Whole Genome Amplification kit according to manu-
facturer recommendations (Sigma-Aldrich) and was used for microsatellite
DNA fingerprinting. Additional detail is available in the Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes one figure, five tables,
Supplemental Experimental Procedures, and one movie and can be found
with this article online at http://dx.doi.org/10.1016/j.stem.2012.07.017.
ACKNOWLEDGMENTS
We would like to acknowledge the outstanding work of Tony Battelli, Pam
Wintruba, and Joe Hrach, the lab animal staff at Magee-Womens Research
institute, who were critical to the conduct of these experiments. Artwork for
the graphical abstract was produced by Dr. Bart Phillips. We are grateful to
Drs. Robert Donahue and Cynthia Dunbar of the National Heart, Lung and
Blood Institute, NIH, who provided critical advice for PBSC transplantation
in nonhuman primates. Drs. Tony Plant and Judy Cameron provided advice
about central line catheter placement in nonhuman primates. We also thank
Drs. Regina Norris, Danielle Sweeney, David Rodeberg, and Francis Schneck
from the Departments of Urology and General Surgery at the Children’s
Hospital of Pittsburgh of UPMC for their assistance with subcapsular testis
biopsies. The FUGW lentiviral backbone was provided by Dr. Carlos Lois,
University of Massachusetts. The anti-CD154 reagent used in these studies
was provided by the NIH Nonhuman Primate Reagent Resource (R24
RR016001, N01 AI040101). The work was supported by Magee-Womens
Research Institute and Foundation, The Richard King Mellon Foundation,
NIH grants R01 HD055475 and R21 HD061289 to K.E.O., U54 HD008610
to Tony M. Plant and K.E.O., P01 HD047675 to G.P.S., and K99/R00
HD062687 to B.P.H.
Received: January 26, 2012
Revised: June 16, 2012
Accepted: July 12, 2012
Published: November 1, 2012
REFERENCES
Alizadeh, M., Bernard, M., Danic, B., Dauriac, C., Birebent, B., Lapart, C.,
Lamy, T., Le Prise´, P.Y., Beauplet, A., Bories, D., et al. (2002). Quantitative
assessment of hematopoietic chimerism after bone marrow transplantation
by real-time quantitative polymerase chain reaction. Blood 99, 4618–4625.
Amann, R.P., Johnson, L., Thompson, D.L., Jr., and Pickett, B.W. (1976). Daily
spermatozoal production, epididymal spermatozoal reserves and transit time
of spermatozoa through the epididymis of the rhesus monkey. Biol. Reprod.
15, 586–592.
Appelbaum, F.R. (2007). Hematopoietic-cell transplantation at 50. N. Engl. J.
Med. 357, 1472–1475.
Bavister, B.D., Boatman, D.E., Collins, K., Dierschke, D.J., and Eisele, S.G.
(1984). Birth of rhesus monkey infant after in vitro fertilization and nonsurgical
embryo transfer. Proc. Natl. Acad. Sci. USA 81, 2218–2222.724 Cell Stem Cell 11, 715–726, November 2, 2012 ª2012 Elsevier InBrinster, R.L. (2002). Germline stem cell transplantation and transgenesis.
Science 296, 2174–2176.
Brinster, R.L. (2007). Male germline stem cells: frommice tomen. Science 316,
404–405.
Brinster, R.L., and Avarbock, M.R. (1994). Germline transmission of donor
haplotype following spermatogonial transplantation. Proc. Natl. Acad. Sci.
USA 91, 11303–11307.
Brinster, R.L., and Zimmermann, J.W. (1994). Spermatogenesis followingmale
germ-cell transplantation. Proc. Natl. Acad. Sci. USA 91, 11298–11302.
Byrne, J.A., Pedersen, D.A., Clepper, L.L., Nelson, M., Sanger, W.G., Gokhale,
S., Wolf, D.P., and Mitalipov, S.M. (2007). Producing primate embryonic stem
cells by somatic cell nuclear transfer. Nature 450, 497–502.
Chan, A.W., Chong, K.Y., Martinovich, C., Simerly, C., and Schatten, G. (2001).
Transgenic monkeys produced by retroviral gene transfer into mature oocytes.
Science 291, 309–312.
Clark, A.T., Phillips, B.T., and Orwig, K.E. (2011). Fruitful progress to fertility:
male fertility in the test tube. Nat. Med. 17, 1564–1565.
Clermont, Y., and Antar, M. (1973). Duration of the cycle of the seminiferous
epithelium and the spermatogonial renewal in the monkey Macaca arctoides.
Am. J. Anat. 136, 153–165.
Copelan, E.A. (2006). Hematopoietic stem-cell transplantation. N. Engl. J.
Med. 354, 1813–1826.
Crouch, B.G., and Overman, R.R. (1957). Chemical protection against x-radi-
ation death in primates: a preliminary report. Science 125, 1092.
Dobrinski, I., Avarbock, M.R., and Brinster, R.L. (1999). Transplantation of
germ cells from rabbits and dogs into mouse testes. Biol. Reprod. 61, 1331–
1339.
Dobrinski, I., Avarbock, M.R., and Brinster, R.L. (2000). Germ cell transplanta-
tion from large domestic animals into mouse testes. Mol. Reprod. Dev. 57,
270–279.
Donahue, R.E., Kuramoto, K., and Dunbar, C.E. (2005). Sources and Methods
to obtain Stem and Progenitor Cells. In Current Protocols in Immunology
(Hoboken, NJ: John Wiley & Sons, Inc.), 22A.1.1–22A.1.29.
Ezzelarab, M.,Welchons, D., Torres, C., Hara, H., Long, C., Yeh, P., Ayares, D.,
and Cooper, D.K. (2008). Atorvastatin down-regulates the primate cellular
response to porcine aortic endothelial cells in vitro. Transplantation 86,
733–737.
Fijak, M., and Meinhardt, A. (2006). The testis in immune privilege. Immunol.
Rev. 213, 66–81.
Geens, M., Goossens, E., De Block, G., Ning, L., Van Saen, D., and Tournaye,
H. (2008). Autologous spermatogonial stem cell transplantation inman: current
obstacles for a future clinical application. Hum. Reprod. Update 14, 121–130.
Ginsberg, J.P., Carlson, C.A., Lin, K., Hobbie, W.L., Wigo, E., Wu, X., Brinster,
R.L., and Kolon, T.F. (2010). An experimental protocol for fertility preservation
in prepubertal boys recently diagnosed with cancer: a report of acceptability
and safety. Hum. Reprod. 25, 37–41.
Gould, K.G., and Mann, D.R. (1988). Comparison of electrostimulation
methods for semen recovery in the rhesus monkey (Macaca mulatta).
J. Med. Primatol. 17, 95–103.
Green, D.M., Kawashima, T., Stovall, M., Leisenring, W., Sklar, C.A., Mertens,
A.C., Donaldson, S.S., Byrne, J., and Robison, L.L. (2010). Fertility of male
survivors of childhood cancer: a report from the Childhood Cancer Survivor
Study. J. Clin. Oncol. 28, 332–339.
Hermann, B.P., and Orwig, K.E. (2011). Translating spermatogonial stem cell
transplantation to the clinic. In Male Germline Stem Cells: Developmental
and Regenerative Potential, K.E. Orwig and B.P. Hermann, eds. (New York,
NY: Humana Press).
Hermann, B.P., Sukhwani, M., Lin, C.C., Sheng, Y., Tomko, J., Rodriguez, M.,
Shuttleworth, J.J., McFarland, D., Hobbs, R.M., Pandolfi, P.P., et al. (2007).
Characterization, cryopreservation, and ablation of spermatogonial stem cells
in adult rhesus macaques. Stem Cells 25, 2330–2338.
Hermann, B.P., Sukhwani, M., Simorangkir, D.R., Chu, T., Plant, T.M., and
Orwig, K.E. (2009). Molecular dissection of themale germ cell lineage identifiesc.
Cell Stem Cell
Spermatogonial Stem Cell Transplantation in Primatesputative spermatogonial stem cells in rhesus macaques. Hum. Reprod. 24,
1704–1716.
Hermann, B.P., Sukhwani, M., Hansel, M.C., and Orwig, K.E. (2010).
Spermatogonial stem cells in higher primates: are there differences from those
in rodents? Reproduction 139, 479–493.
Hermann, B.P., Sukhwani, M., Salati, J., Sheng, Y., Chu, T., and Orwig, K.E.
(2011). Separating spermatogonia from cancer cells in contaminated prepu-
bertal primate testis cell suspensions. Hum. Reprod. 26, 3222–3231.
Herrid, M., Olejnik, J., Jackson, M., Suchowerska, N., Stockwell, S., Davey, R.,
Hutton, K., Hope, S., and Hill, J.R. (2009). Irradiation enhances the efficiency of
testicular germ cell transplantation in sheep. Biol. Reprod. 81, 898–905.
Hewitson, L., Dominko, T., Takahashi, D., Martinovich, C., Ramalho-Santos,
J., Sutovsky, P., Fanton, J., Jacob, D., Monteith, D., Neuringer, M., et al.
(1999). Unique checkpoints during the first cell cycle of fertilization after intra-
cytoplasmic sperm injection in rhesus monkeys. Nat. Med. 5, 431–433.
Honaramooz, A., Megee, S.O., and Dobrinski, I. (2002). Germ cell transplanta-
tion in pigs. Biol. Reprod. 66, 21–28.
Honaramooz, A., Behboodi, E., Megee, S.O., Overton, S.A., Galantino-Homer,
H., Echelard, Y., and Dobrinski, I. (2003). Fertility and germline transmission of
donor haplotype following germ cell transplantation in immunocompetent
goats. Biol. Reprod. 69, 1260–1264.
Izadyar, F., Den Ouden, K., Stout, T.A., Stout, J., Coret, J., Lankveld, D.P.,
Spoormakers, T.J., Colenbrander, B., Oldenbroek, J.K., Van der Ploeg, K.D.,
et al. (2003). Autologous and homologous transplantation of bovine spermato-
gonial stem cells. Reproduction 126, 765–774.
Jahnukainen, K., Ehmcke, J., Quader, M.A., Saiful Huq, M., Epperly, M.W.,
Hergenrother, S., Nurmio, M., and Schlatt, S. (2011). Testicular recovery after
irradiation differs in prepubertal and pubertal non-human primates, and can be
enhanced by autologous germ cell transplantation. Hum. Reprod. 26, 1945–
1954.
Kang, E.M., Hsieh, M.M., Metzger, M., Krouse, A., Donahue, R.E., Sadelain,
M., and Tisdale, J.F. (2006). Busulfan pharmacokinetics, toxicity, and low-
dose conditioning for autologous transplantation of genetically modified
hematopoietic stem cells in the rhesus macaque model. Exp. Hematol. 34,
132–139.
Keros, V., Hultenby, K., Borgstro¨m, B., Fridstro¨m, M., Jahnukainen, K., and
Hovatta, O. (2007). Methods of cryopreservation of testicular tissue with viable
spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treat-
ment. Hum. Reprod. 22, 1384–1395.
Khouangsathiene, S., Pearson, C., Street, S., Ferguson, B., and Dubay, C.
(2008). MonkeySNP: a web portal for non-human primate single nucleotide
polymorphisms. Bioinformatics 24, 2645–2646.
Kim, Y., Turner, D., Nelson, J., Dobrinski, I., McEntee, M., and Travis, A.J.
(2008). Production of donor-derived sperm after spermatogonial stem cell
transplantation in the dog. Reproduction 136, 823–831.
Kirk, A.D., Burkly, L.C., Batty, D.S., Baumgartner, R.E., Berning, J.D.,
Buchanan, K., Fechner, J.H., Jr., Germond, R.L., Kampen, R.L., Patterson,
N.B., et al. (1999). Treatment with humanized monoclonal antibody against
CD154 prevents acute renal allograft rejection in nonhuman primates. Nat.
Med. 5, 686–693.
Kubota, H., and Brinster, R.L. (2006). Technology insight: In vitro culture of
spermatogonial stem cells and their potential therapeutic uses. Nat. Clin.
Pract. Endocrinol. Metab. 2, 99–108.
Larsen, C.P., Page, A., Linzie, K.H., Russell, M., Deane, T., Stempora, L.,
Strobert, E., Penedo, M.C., Ward, T., Wiseman, R., et al. (2010). An MHC-
defined primatemodel reveals significant rejection of bonemarrow after mixed
chimerism induction despite full MHC matching. Am. J. Transplant. 10, 2396–
2409.
Lee, S.J., Schover, L.R., Partridge, A.H., Patrizio, P., Wallace, W.H., Hagerty,
K., Beck, L.N., Brennan, L.V., and Oktay, K.; American Society of Clinical
Oncology. (2006). American Society of Clinical Oncology recommendations
on fertility preservation in cancer patients. J. Clin. Oncol. 24, 2917–2931.CellLois, C., Hong, E.J., Pease, S., Brown, E.J., and Baltimore, D. (2002). Germline
transmission and tissue-specific expression of transgenes delivered by lentivi-
ral vectors. Science 295, 868–872.
Mauch, P., Constine, L., Greenberger, J., Knospe, W., Sullivan, J., Liesveld,
J.L., and Deeg, H.J. (1995). Hematopoietic stem cell compartment: acute
and late effects of radiation therapy and chemotherapy. Int. J. Radiat.
Oncol. Biol. Phys. 31, 1319–1339.
Meistrich, M.L. (1993). Effects of chemotherapy and radiotherapy on sper-
matogenesis. Eur. Urol. 23, 136–141, discussion 142.
Messaoudi, I., Estep, R., Robinson, B., and Wong, S.W. (2011). Nonhuman
primate models of human immunology. Antioxid. Redox Signal. 14, 261–273.
Mikkola, M., Sironen, A., Kopp, C., Taponen, J., Sukura, A., Vilkki, J., Katila, T.,
and Andersson, M. (2006). Transplantation of normal boar testicular cells
resulted in complete focal spermatogenesis in a boar affected by the immotile
short-tail sperm defect. Reprod. Domest. Anim. 41, 124–128.
Mitalipov, S., Kuo, H.C., Byrne, J., Clepper, L., Meisner, L., Johnson, J., Zeier,
R., and Wolf, D. (2006). Isolation and characterization of novel rhesus monkey
embryonic stem cell lines. Stem Cells 24, 2177–2186.
Mitchell, R.T., Saunders, P.T., Sharpe, R.M., Kelnar, C.J., and Wallace, W.H.
(2009). Male fertility and strategies for fertility preservation following childhood
cancer treatment. Endocr. Dev. 15, 101–134.
Ogawa, T. (2001). Spermatogonial transplantation: the principle and possible
applications. J. Mol. Med. 79, 368–374.
Ogawa, T., Dobrinski, I., and Brinster, R.L. (1999). Recipient preparation is crit-
ical for spermatogonial transplantation in the rat. Tissue Cell 31, 461–472.
Ogawa, T., Dobrinski, I., Avarbock, M.R., and Brinster, R.L. (2000).
Transplantation of male germ line stem cells restores fertility in infertile mice.
Nat. Med. 6, 29–34.
Oktay, K. (2011). Institute for Fertility Preservation at the Center for Human
Reproduction, Center for Reproductive Medicine, New York Medical
College. http://www.fertilitypreservation.org.
Orwig, K.E., Sanfilippo, J.S., Shaw, P.H., Cannon, G.M., and Dovey, S.L.
(2011). Fertility Preservation Program in Pittsburgh, Magee-Womens
Research Institute, University of Pittsburgh Medical Center. http://www.
mwrif.org/220.
Osawa, M., Hanada, K., Hamada, H., and Nakauchi, H. (1996). Long-term
lymphohematopoietic reconstitution by a single CD34-low/negative hemato-
poietic stem cell. Science 273, 242–245.
Phillips, B.T., Gassei, K., and Orwig, K.E. (2010). Spermatogonial stem cell
regulation and spermatogenesis. Philos. Trans. R. Soc. Lond. B Biol. Sci.
365, 1663–1678.
Plant, T.M., and Marshall, G.R. (2001). The functional significance of FSH in
spermatogenesis and the control of its secretion in male primates. Endocr.
Rev. 22, 764–786.
Potten, C.S. (1992). Cell lineages. In Oxford Textbook of Pathology, J.O.
McGee, P.G. Isaacson, and N.A. Wright, eds. (Oxford: Oxford University
Press), pp. 43–52.
Potten, C.S. (1995). Interleukin-11 protects the clonogenic stem cells in murine
small-intestinal crypts from impairment of their reproductive capacity by radi-
ation. Int. J. Cancer 62, 356–361.
Potten, C.S., Schofield, R., and Lajtha, L.G. (1979). A comparison of cell
replacement in bone marrow, testis and three regions of surface epithelium.
Biochim. Biophys. Acta 560, 281–299.
Powell, J.L., Hingorani, P., and Kolb, E.A. (2009). Pediatric Hematopoietic
Stem Cell Transplantation. Medscape Reference WebMD LLC, 09/11/2009.
http://emedicine.medscape.com/article/991032-overview.
Rodriguez-Sosa, J.R., and Dobrinski, I. (2009). Recent developments in testis
tissue xenografting. Reproduction 138, 187–194.
Ryu, B.Y., Orwig, K.E., Avarbock,M.R., and Brinster, R.L. (2003). Stem cell and
niche development in the postnatal rat testis. Dev. Biol. 263, 253–263.
Sadri-Ardekani, H., Akhondi, M.A., van der Veen, F., Repping, S., and van Pelt,
A.M. (2011). In vitro propagation of human prepubertal spermatogonial stem
cells. JAMA 305, 2416–2418.Stem Cell 11, 715–726, November 2, 2012 ª2012 Elsevier Inc. 725
Cell Stem Cell
Spermatogonial Stem Cell Transplantation in PrimatesSato, T., Katagiri, K., Gohbara, A., Inoue, K., Ogonuki, N., Ogura, A., Kubota,
Y., and Ogawa, T. (2011). In vitro production of functional sperm in cultured
neonatal mouse testes. Nature 471, 504–507.
Schlatt, S., and Kliesch, S. (2012). Center for Reproductive Medicine and
Andrology, University of Mu¨nster. http://repro.klinikum.uni-muenster.de/
html/quadega.html.
Schlatt, S., Rosiepen, G., Weinbauer, G.F., Rolf, C., Brook, P.F., and
Nieschlag, E. (1999). Germ cell transfer into rat, bovine, monkey and human
testes. Hum. Reprod. 14, 144–150.
Schlatt, S., Foppiani, L., Rolf, C., Weinbauer, G.F., and Nieschlag, E. (2002).
Germ cell transplantation into X-irradiated monkey testes. Hum. Reprod. 17,
55–62.
Schlatt, S., Ehmcke, J., and Jahnukainen, K. (2009). Testicular stem cells for
fertility preservation: preclinical studies on male germ cell transplantation
and testicular grafting. Pediatr. Blood Cancer 53, 274–280.
Sharpe, R.M. (1994). Regulation of Spermatogenesis. In The Physiology of
Reproduction, E. Knobil and J.D. Neill, eds. (New York: Raven Press, Ltd.),
pp. 1363–1434.
Shinohara, T., Orwig, K.E., Avarbock, M.R., and Brinster, R.L. (2001).
Remodeling of the postnatal mouse testis is accompanied by dramatic726 Cell Stem Cell 11, 715–726, November 2, 2012 ª2012 Elsevier Inchanges in stem cell number and niche accessibility. Proc. Natl. Acad. Sci.
USA 98, 6186–6191.
Thomas, E.D., Lochte, H.L., Jr., Lu, W.C., and Ferrebee, J.W. (1957).
Intravenous infusion of bone marrow in patients receiving radiation and
chemotherapy. N. Engl. J. Med. 257, 491–496.
Wallace, W.H., Anderson, R.A., and Irvine, D.S. (2005). Fertility preservation for
young patients with cancer: who is at risk and what can be offered? Lancet
Oncol. 6, 209–218.
Wolf, D.P., Vandevoort, C.A., Meyer-Haas, G.R., Zelinski-Wooten, M.B., Hess,
D.L., Baughman, W.L., and Stouffer, R.L. (1989). In vitro fertilization and
embryo transfer in the rhesus monkey. Biol. Reprod. 41, 335–346.
Wolf, D.P., Thormahlen, S., Ramsey, C., Yeoman, R.R., Fanton, J., and
Mitalipov, S. (2004). Use of assisted reproductive technologies in the propaga-
tion of rhesus macaque offspring. Biol. Reprod. 71, 486–493.
Wyns, C., Van Langendonckt, A., Wese, F.X., Donnez, J., and Curaba, M.
(2008). Long-term spermatogonial survival in cryopreserved and xenografted
immature human testicular tissue. Hum. Reprod. 23, 2402–2414.
Wyns, C., Curaba, M., Vanabelle, B., Van Langendonckt, A., and Donnez, J.
(2010). Options for fertility preservation in prepubertal boys. Hum. Reprod.
Update 16, 312–328.c.
